España
Buscar    
Incluir todos los sitios de CSL Behring

Fibrogammin® P

Human plasma coagulation factor XIII.

Powder and diluent (water for injections) for intravenous injection or infusion. Fibrogammin P

Therapeutic indications

  • Congenital deficiency of Factor XIII and resulting haemorrhagic syndromes, haemorrhages and disturbances in wound healing.
  • Haemorrhagic diatheses caused in part by acquired Factor-XIII-deficiency, e.g. in acute cases of leukosis and liver diseases (acute phase in cirrhosis and dystrophy of the liver), and in consumption coagulopathy.
  • To promote healing of wounds.
  • To promote healing of bone fractures.

Last Updated: 27.02.2007